XML 51 R45.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Equity and Other Investments and Fair Value Measurements - Convertible Promissory Note in Gate Neuroscience (Details) - USD ($)
$ in Thousands
3 Months Ended
Feb. 13, 2024
Oct. 06, 2023
Feb. 02, 2023
Nov. 24, 2021
Mar. 31, 2024
Mar. 31, 2023
Dec. 31, 2023
Equity Investment              
Additional cash investment         $ 0 $ 35,689  
Gate Neuroscience [Member]              
Equity Investment              
Number of common stock issued description       The number of common stock shares to be issued in a qualified event shall be equal to the amount due on the conversion date divided by the lesser of a capped conversion price (the “Capped Conversion Price”) and the qualified event price (the “Qualified Event Price”). The Capped Conversion Price is calculated as $50.0 million divided by the number of shares of common stock outstanding at such time on a fully diluted basis. The Qualified Event Price is the price per share determined by the qualified event. A qualified financing is a sale or series of sales of preferred stock where (i) at least 50 percent of counterparties are not existing shareholders, (ii) net proceeds to Gate are at least $35.0 million, and (iii) the stated or implied equity valuation of Gate is at least $80.0 million.      
Additional cash investment $ 5,000 $ 5,000 $ 5,000        
Equity and long-term investments at fair value         33,200   $ 28,000
Unrealized loss from fair value changes in equity investments         $ 600 $ 700  
Convertible Promissory Note Purchase Agreement | Gate Neuroscience [Member]              
Equity Investment              
Convertible notes Face Value   27,700 21,500 $ 15,000      
Debt instrument principal amount       $ 15,000      
Debt Instrument, Interest Rate, Effective Percentage       8.00%      
Note Amendment Agreement | Gate Neuroscience [Member]              
Equity Investment              
Convertible notes Face Value     $ 21,500        
Second Note Amendment Agreement | Gate Neuroscience [Member]              
Equity Investment              
Convertible notes Face Value   $ 27,700          
Third Note Amendment Agreement | Gate Neuroscience [Member]              
Equity Investment              
Convertible notes Face Value $ 33,500